Trends in Radiation Therapy among Cancer Survivors in the United States, 2000-2030

Autor: Matthew P. Banegas, Maria Elena Martinez, James D. Murphy, Alex K. Bryant, Loren K. Mell
Rok vydání: 2017
Předmět:
Oncology
Gerontology
Male
History
Aging
Colorectal cancer
Epidemiology
medicine.medical_treatment
Medical and Health Sciences
Prostate cancer
0302 clinical medicine
Cancer Survivors
80 and over
030212 general & internal medicine
Child
Cancer
Aged
80 and over

education.field_of_study
Incidence (epidemiology)
Rehabilitation
Middle Aged
21st Century
humanities
030220 oncology & carcinogenesis
Child
Preschool

population characteristics
Female
Patient Safety
Adult
medicine.medical_specialty
Adolescent
Population
History
21st Century

03 medical and health sciences
Young Adult
Rare Diseases
Internal medicine
medicine
Humans
education
Preschool
Aged
Radiotherapy
business.industry
Prevention
Head and neck cancer
Infant
Newborn

Infant
social sciences
medicine.disease
Newborn
United States
Radiation therapy
Good Health and Well Being
business
Zdroj: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol 26, iss 6
Bryant, AK; Banegas, MP; Martinez, ME; Mell, LK; & Murphy, JD. (2017). Trends in Radiation Therapy among Cancer Survivors in the United States, 2000-2030. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 26(6), 963-970. doi: 10.1158/1055-9965.EPI-16-1023. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/55f8884v
Popis: Background: Although the number of cancer survivors has increased substantially over the past several decades, the composition of survivors treated with radiotherapy is not well defined. Radiotherapy carries unique long-term toxicity risks for cancer survivors. This study describes the current estimates and future projections of the epidemiology of 5-year cancer survivors who receive radiation therapy. Methods: We used cancer incidence and survival data from the Surveillance, Epidemiology, and End-Results (SEER) database linked to U.S. Census data to estimate the number of 5-year cancer survivors treated with radiation between 2000 and 2030. Future projections assumed continuing incidence and survival trends based on historical rates. Results: In 2016, there were an estimated 3.05 million cancer survivors treated with radiation, accounting for 29% of all cancer survivors. The number of radiation-treated cancer survivors is projected to reach 3.38 million by 2020 and 4.17 million by 2030. In 2016, breast (40%) and prostate cancer (23%) composed the majority of radiation-treated survivors, followed by head and neck cancer (5.8%), lymphoma (5.6%), uterine (3.9%), and rectal cancer (3.8%). The percentage of 70 years or older radiation-treated survivors steadily increased between 2000 and 2030. Conclusions: The next several years are projected to see a large increase in the number of cancer survivors treated with radiation. Impact: This group of cancer survivors has unique needs given the long-term risks of radiation, and increased research and awareness are required to optimize health of this growing population. Cancer Epidemiol Biomarkers Prev; 26(6); 963–70. ©2017 AACR.
Databáze: OpenAIRE